Navigation Links
Kendle Announces Fourth Quarter and Full-Year 2010 Results
Date:3/2/2011

wth rates and on Kendle's ability to preserve profitability while managing global operations, (d) changes in regulation of the drug-development process, (e) changes in tax legislation, including proposed changes related to non-U.S. earnings, (f) the potential for contracts to be reduced in scope, terminated, or delayed with little or no notice, (g) the fixed-price nature of contracts and cost overruns, (h) the ability to continue to attract physician investigators to supervise administration of study drugs and patient volunteers to participate in clinical trials, (i) the amount of goodwill and other intangible assets on Kendle's balance sheet and the potential for write-downs of these assets if they become impaired under accounting rules, (j) Kendle's ability to service its indebtedness and maintain adequate credit facilities and credit lines, (k) risks from Kendle's various counterparties, (l) risks related to Kendle's international operations, (m) exposure to foreign currency exchange rate fluctuations, (n) dependence on the continued effectiveness and availability of information technology infrastructure, (o) implementation and deployment of Kendle's enterprise-wide reporting solution, (p) litigation and regulatory risk incident to Kendle's business, (q) dependence on the skills, experience and ongoing efforts of employees and management team in the geographic regions and therapeutic areas in which Kendle operates, (r) effects of new or revised accounting standards on Kendle's consolidated financial statements, and (s) other risks as detailed from time to time in Kendle's Annual Report on Form 10-K as well as periodic reports filed with the SEC.   In addition, no assurance can be given that Kendle will be able to realize the net service revenues from the contracts and awards included in backlog. Kendle believes that its aggregate backlog is not necessarily a meaningful indicator of future results. All information in this press release is current as of March
'/>"/>
SOURCE Kendle International Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Kendle Appoints Martha Feller, PhD, Vice President and Global Head, Study Start-up
2. Kendle Announces CEO Succession Plan, Promotes Stephen Cutler, PhD, to President and CEO
3. Kendle to Present at Lazard Capital Markets 7th Annual Healthcare Conference
4. Kendle Announces Details Regarding Third Quarter 2010 Earnings Conference Call and Webcast
5. Kendle Appoints Mark J. Roseman, D.Sc., Senior Vice President and Chief Marketing Officer
6. Kendle Announces Details Regarding Second Quarter 2010 Earnings Conference Call and Webcast
7. Kendle to Present at 2010 Wells Fargo Securities Healthcare Conference
8. Kendle Advances Early Stage Drug Development with ElMindAs Innovative Brain Network Activation Technology
9. Kendle Director of Global Safety and Pharmacovigilance, Drew Kilpatrick, PhD, Named One of Ten Notable People in R&D
10. Kendle Executive to Share Insights at World Pharma Trials Asia 2010
11. Kendle is First Global CRO to Achieve ISO 9001:2008 Certification in China Through Beijing Affiliate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... Calif. , July 22, 2014  Based ... imaging (MRI) market, Frost & Sullivan recognizes Siemens ... Product Leadership. Siemens Healthcare,s FREEZEit solution, which employs ... need for robust and motion-insensitive imaging. The solution,s ... the evolution of body MRI imaging in the ...
(Date:7/22/2014)... , July 22, 2014 Sanofi Pasteur, the ... SNY ), announced today that the first lots of Fluzone ... season have been released by the U.S. Food and Drug ... 21, 2014, representing the first of at least 65 million ... will be delivered to U.S. health care providers and pharmacies ...
(Date:7/22/2014)... , July 22, 2014 Galmed Pharmaceuticals Ltd. ... company focused on the development and commercialization of a ... and cholesterol gallstones, announced today that the U.S. Food ... New Drug, or IND, application.  Such clearance will permit ... aramchol, in the United States ...
Breaking Medicine Technology:Frost & Sullivan Recognizes Siemens Healthcare with the Product Leadership Award for Innovative Techniques in Abdominal Imaging 2Frost & Sullivan Recognizes Siemens Healthcare with the Product Leadership Award for Innovative Techniques in Abdominal Imaging 3Frost & Sullivan Recognizes Siemens Healthcare with the Product Leadership Award for Innovative Techniques in Abdominal Imaging 4Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 2Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 3Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 4Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 5Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 6Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for Upcoming 2014-2015 Season in United States 7Galmed Announces FDA Clearance of IND of Armachol for the Treatment of Fatty Liver Disorders 2Galmed Announces FDA Clearance of IND of Armachol for the Treatment of Fatty Liver Disorders 3Galmed Announces FDA Clearance of IND of Armachol for the Treatment of Fatty Liver Disorders 4
... Catalyst Pharmaceutical Partners, Inc. (Nasdaq: CPRX ) today announced ... of 3.97 million shares of its common stock to institutional ... proceeds of $3.97 million. , The shares were offered ... the Securities and Exchange Commission that was declared effective on ...
... FRANKLIN LAKES, N.J., Oct. 6 BD (Becton, Dickinson and ... conduct a live webcast of its fourth fiscal quarter and ... 4, 2009 at 10:00 a.m. (ET). BD will issue ... , The webcast of the conference call, along with related ...
Cached Medicine Technology:Catalyst Pharmaceutical Partners, Inc. Announces the Closing of $3.97 Million Registered Direct Offering 2
(Date:7/22/2014)... New York, NY (PRWEB) July 22, 2014 ... ( http://www.xareltolawsuitcenter.com/ ) that alleges the death ... bleeding caused by the blood thinner, Bernstein Liebhard LLP ... the U.S. District Court for the Southern District ... Xarelto in January 2012, and suffered a subdural hemorrhage ...
(Date:7/22/2014)... a minimally invasive hysterectomy using electric power morcellation, uterine ... the time of the procedure, according to a study ... that this procedure, in which the uterus is fragmented ... undetected malignancies. , Despite the commercial availability of electric ... prevalence of malignancy at the time of electric power ...
(Date:7/22/2014)... D.C. (PRWEB) July 22, 2014 ... “Ensuring Seniors Access to Local Pharmacies Act of ... Medicare Part D would undermine the availability of ... spending by $21 billion over the next 10 ... Company released by the Pharmaceutical Care Management Association ...
(Date:7/22/2014)... Cancer (LALCA 2014) will be held August 21 ... still the leading cause of death not only in ... the previous conferences in Chile, Mexico, Argentina and Brazil, ... advances in the treatment and prevention of lung cancer ... , With tobacco being the leading cause of morbi-mortality ...
(Date:7/22/2014)... July 22, 2014 The park is ... the Kendalltown Homeowners Association, Inc., made a ... residential community with the purchase of playground equipment from ... located in beautiful Miami Florida, and is a 475-unit ... of the surrounding landscape has created a tropical paradise ...
Breaking Medicine News(10 mins):Health News:Xarelto Lawsuit Filed by Florida Woman Alleges Uncontrollable Bleeding Led to Husband’s Death, Bernstein Liebhard LLP Reports 2Health News:Xarelto Lawsuit Filed by Florida Woman Alleges Uncontrollable Bleeding Led to Husband’s Death, Bernstein Liebhard LLP Reports 3Health News:Study examines presence of uterine cancers at the time of hysterectomy using morcellation 2Health News:PCMA: New Study Finds H.R. 4577 to Cost $21 Billion Over 10 Years 2Health News:Fun in the Florida Sun: Kendalltown Homeowners Association Inc. Expands Outdoor Recreation with American Parks Company™ 2Health News:Fun in the Florida Sun: Kendalltown Homeowners Association Inc. Expands Outdoor Recreation with American Parks Company™ 3
... will focus on scientist collaboration and streamlining the drug discovery process. , , SAN DIEGO, June 18 , ... Meeting in San Diego, Microsoft Corp. ... solutions designed for the life sciences industry, ... * Trial Launch and Protocol Authoring With the 2007 Microsoft, ...
... food and grocery stores , , CHICAGO, June 18 ... of Food Deserts on Public Health in Chicago identified more ... food is hard to come by because of the lack of ... market, community and government actors used the report to take action. ...
... ... Simon will teach stressed New Yorkers how to heal anxiety and experience greater physical health and ... New York City, NY ... Wellbeing , David Simon, M.D., is coming to New York City this June with the launch ...
... introduces proven behavioral health programs from Health Integrated to ... Health Plan members with behavioral health conditions , ... Plan, the nation,s largest public health plan, and Health ... are collaborating to improve outcomes for populations being served ...
... 18 The Sebastian Ferrero Foundation has ... marketing, promotions and publicity. The Gainesville, Florida based firm will begin ... Noche de Gala taking place October 3, 2009. ... an excellent agency with a proven track record of innovation and ...
... Connectyx (Pink Sheets: CTYX) - Connectyx Technologies Holdings Group, ... into an agreement with Sabrielle GPS High Tech to distribute ... Asia market. The initial sales will be targeted to ... allows for the expansion into neighboring countries starting as early ...
Cached Medicine News:Health News:Microsoft to Showcase Clinical Trial Solutions From Discovery to Approvals at Drug Information Association's 2009 Annual Meeting 2Health News:Chicago Making Progress Shrinking Vast 'Food Desert' 2Health News:Chopra Center Co-Founder and Best-Selling Author David Simon, M.D., Will Lead Two Special Events in New York City This June 2Health News:Chopra Center Co-Founder and Best-Selling Author David Simon, M.D., Will Lead Two Special Events in New York City This June 3Health News:L.A. Care Health Plan and Health Integrated Partner to Integrate Medical and Behavioral Support Programs for L.A. Care's Providers 2Health News:L.A. Care Health Plan and Health Integrated Partner to Integrate Medical and Behavioral Support Programs for L.A. Care's Providers 3Health News:Sebastian Ferrero Foundation Selects Gainesville, Florida Based Frankel Media Group as Agency of Record 2Health News:Connectyx Technologies Signs Distributor to Serve the Vast South East Asia Market with its MedFlash Electronic Personal Health Record 2
... Titanium Staples for use with PI™ (Single ... ,The PI™ disposable stapler is designed for ... normal, healthy internal tissues. The instrument places ... row, when using the 30 VASCULAR cartridges) ...
... GIA™ Reloadable Staplers and the SGIA™ ... gynecological, pediatric and thoracic surgical procedures ... anastomosis. , ,The Auto Suture™ ... Knifeless Stapler have application in abdominal, ...
... are anastomotic staplers available in four sizes ... lumen diameter. The staplers permit tissue attachment ... access and ease of use. The instruments ... by adjusting the height of the closed ...
... Sizer Device for use with ... Anastomosis Ring)., ,The Purstring™ ... colorectal and esophageal surgery for ... sutures and is intended for ...
Medicine Products: